Mordor Intelligence has published a new report on the Pharmaceutical Contract Manufacturing Organization (CMO) Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
-- Pharmaceutical CMO Market Overview
The Pharmaceutical Contract Manufacturing Organization Market is experiencing sustained expansion as pharmaceutical companies increasingly focus on core competencies such as drug discovery, pipeline differentiation, and global commercialization, while outsourcing manufacturing activities to specialized partners.
According to Mordor Intelligence, the Pharmaceutical Contract Manufacturing Organization (CMO) Market Size is projected to grow from USD 184.44 billion in 2025 to USD 196.33 billion in 2026, and further reach USD 268.37 billion by 2031, registering a CAGR of 6.45% during the forecast period.
The Pharmaceutical CMO Industry plays a critical role across the value chain, supporting active pharmaceutical ingredient (API) manufacturing, finished dosage formulation, secondary packaging, and regulatory-compliant production for both innovator and generic drug manufacturers.
Key Trends Shaping the Pharmaceutical Contract Manufacturing Organization Market
Rising demand for biologics and advanced therapy manufacturing
The increasing complexity of biologics, cell therapies, and gene therapies is a key factor supporting pharmaceutical contract manufacturing organization market growth. These therapies require specialized infrastructure, controlled environments, and advanced quality systems, reinforcing the role of experienced CMOs within the pharmaceutical contract manufacturing organization industry.
Boosting market demand through the expansion of virtual biotech companies
The rapid emergence of venture-backed virtual biotech companies is boosting demand across the pharmaceutical contract manufacturing organization market. These asset-light firms depend heavily on external manufacturing partners, supporting long-term capacity utilization and service diversification among CMOs.
Increasing demand for high-potency APIs driven by oncology pipelines
Rising oncology-focused drug development is increasing demand for high-potency active pharmaceutical ingredients (HPAPIs). The specialized containment systems and stringent safety protocols required for HPAPI production reinforce the importance of capable CMOs, contributing to sustained pharmaceutical contract manufacturing organization market growth.
Expanding integrated end-to-end manufacturing and packaging services
CMOs are increasingly expanding their service portfolios to offer integrated solutions spanning API manufacturing, finished dosage formulation, and secondary packaging. This trend is strengthening the pharmaceutical contract manufacturing organization market share among full-service providers by enabling faster time-to-market and simplified supplier management for pharmaceutical clients.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/pharmaceutical-contract-manufacturing-organization-cmo-market?utm_source=marketersmedia
Pharmaceutical CMO Market Segmentation Insights
By Service Type
- API Manufacturing
- Small Molecule
- Large Molecule
- High-Potency API (HPAPI)
- Finished Dosage Formulation (FDF) Development and Manufacturing
- Solid Dose
- Liquid Dose
- Injectable Dose
- Secondary Packaging
By Drug Molecule Type
- Small Molecule
- Biologics
- Advanced Therapies (Cell and Gene)
By Scale of Operation
- Clinical-Phase Manufacturing
- Commercial-Scale Manufacturing
By End User
- Big Pharma
- Generic Pharma
- Emerging / Virtual Biotech
- Specialty Pharma
By Therapeutic Area
- Oncology
- Cardiovascular
- Central Nervous System
- Infectious Disease
- Other Therapeutic Areas
By Geography
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Explore Our Full Library of Packaging Research Industry Reports: https://www.mordorintelligence.com/market-analysis/packaging?utm_source=marketersmedia
Key Players in the Pharmaceutical CMO Market
- Lonza Group Ltd.
- Catalent Inc.
- Thermo Fisher Scientific Inc.
- Samsung Biologics Co. Ltd
- WuXi Biologics (Cayman) Inc.
These companies collectively account for a significant pharmaceutical contract manufacturing organization (CMO) market share, supported by global manufacturing footprints, diversified service portfolios, and strong regulatory compliance capabilities.
Conclusion
The pharmaceutical contract manufacturing organization market forecast indicates steady and resilient growth as pharmaceutical companies increasingly depend on external partners to manage manufacturing complexity, capacity scalability, and regulatory requirements.
As the market outlook continues to strengthen, providers that combine technical expertise, flexible capacity, and integrated end-to-end services are expected to enhance their competitive positioning. With sustained demand across multiple therapeutic areas and end-user segments, the pharmaceutical CMO market size is set to expand steadily, creating long-term opportunities across the global pharmaceutical supply chain.
For more insights on pharmaceutical contract manufacturing organization (CMO) market, please visit the Mordor Intelligence Page: https://www.mordorintelligence.com/industry-reports/pharmaceutical-contract-manufacturing-organization-cmo-market?utm_source=marketersmedia
Industry Related Reports:
Pharmaceutical (CDMO) Market
The pharmaceutical CDMO market is witnessing steady growth, expanding from USD 258.88 billion in 2025 to USD 374.68 billion by 2031 at a CAGR of 6.33%. Growth is driven by increased outsourcing of drug development and manufacturing, rising biologics complexity, and the need for faster, cost-efficient commercialization.
Asia-Pacific Contract Packaging Market
The Asia Pacific contract packaging market is expected to grow at a strong CAGR of 12% during the forecast period. Expansion is supported by rapid industrialization, increasing outsourcing by FMCG and pharmaceutical companies, and rising demand for flexible and sustainable packaging solutions.
https://www.mordorintelligence.com/industry-reports/asia-pacific-contract-packaging-market?utm_source=marketersmedia
Pharmaceutical Contract Packaging Market
The pharmaceutical contract packaging market is estimated to grow from USD 19.16 billion in 2025 to USD 31.86 billion by 2031, registering a CAGR of 8.84%. Growth is fueled by rising pharmaceutical outsourcing, stringent regulatory requirements, and increasing demand for specialized and compliant packaging solutions.
https://www.mordorintelligence.com/industry-reports/pharmaceutical-contract-packaging-market?utm_source=marketersmedia
About the company: About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries or to access the full report, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/ Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana – 500032, India.
Contact Info:
Name: Jignesh Thakkar
Email: Send Email
Organization: Mordor Intelligence
Address: Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana – 500032, India
Phone: +1 617-765-2493
Website: https://www.mordorintelligence.com/
Release ID: 89182036
If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.
